跳至主要内容
临床试验/NCT00627081
NCT00627081已完成4 期

Intravenous Opioid-sparing Effect of Thoracic Epidural Administration of Chirocaine (5 mg/ml) During Thoracotomy

Hopital Foch1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2008年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Hopital Foch
入组人数
40
试验地点
1
主要终点
amount of remifentanil delivered by the closed-loop system

研究概览

简要总结

The association of general anesthesia and of thoracic epidural anesthesia is used in thoracic surgery with a demonstrated benefit on the risk of postoperative respiratory complications.

The objective of the study is to analyze the influence of thoracic epidural administration of chirocaine (5 mg/ml) on the administration of anesthetic agents (propofol and remifentanil), these drugs being administrated using a closed-loop system with the Bispectral Index as the controller.

Two groups of patients are compared:

  • one group will receive general anesthesia and thoracic epidural administration of saline. Chirocaine will be administered before patient's awakening,
  • one group will receive general anesthesia and thoracic epidural administration of chirocaine (5 mg/ml).

In both groups, the closed-loop system ensures that le depth of anesthesia is similar in both groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing a thoracotomy under general anesthesia and epidural anesthesia

排除标准

  • age lower than 18 years,
  • pregnant woman,
  • psychotropic treatment,
  • central neurological disorder or lesion cerebral,
  • allergy to propofol or to a muscle relaxant,
  • refusal or contra-indication of epidural anesthesia,
  • severe emphysema,
  • coronary disease,
  • treatment with a beta-blocker or a vasoactive drug.

研究组 & 干预措施

1

Placebo Comparator

general anesthesia and thoracic epidural administration of saline

干预措施: remifentanil (Drug)

2

Active Comparator

general anesthesia and thoracic epidural administration of chirocaine

干预措施: remifentanil (Drug)

结局指标

主要结局

amount of remifentanil delivered by the closed-loop system

时间窗: end of anesthesia

次要结局

  • amount of propofol delivered by the closed-loop system(end of anesthesia)

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验